Stay updated on Sage-217 Adjunctive Therapy in Depression Clinical Trial
Sign up to get notified when there's something new on the Sage-217 Adjunctive Therapy in Depression Clinical Trial page.

Latest updates to the Sage-217 Adjunctive Therapy in Depression Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check20 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check35 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check63 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check78 days agoChange DetectedThe page has been updated to include new drug names related to the treatment of Major Depressive Disorder (MDD), specifically Escitalopram, Citalopram, Duloxetine, and Desvenlafaxine, while significant details about the study's purpose and criteria have been removed.SummaryDifference8%
Stay in the know with updates to Sage-217 Adjunctive Therapy in Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sage-217 Adjunctive Therapy in Depression Clinical Trial page.